{"componentChunkName":"component---src-templates-chapter-level-1-chapter-level-1-tsx","path":"/topics/giant-cell-arteritis/references/","result":{"pageContext":{"chapter":{"id":"e1a018ae-4d22-516e-8a99-d688c0d3dda6","slug":"references","fullItemName":"References","depth":1,"htmlHeader":"<!-- begin field 378b0763-1c81-4bac-9bca-dc2833f209a9 --><h1>References</h1><!-- end field 378b0763-1c81-4bac-9bca-dc2833f209a9 -->","summary":null,"htmlStringContent":"<!-- begin item 1d40576f-244e-4ae2-add6-4dcb29143f6a --><!-- begin field 180c409e-3212-4e9c-8510-fa08f5a28422 --><ul class=\"bibliography\"><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Barraclough, K., Mallen, C.D., Helliwell, T.,                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2012</span>) <span property=\"dc:title\">Diagnosis and management of giant cell arteritis</span>. <em>British Journal of General Practice</em> <strong><span rel=\"bibo:volume\">62</span></strong>(<span rel=\"bibo:issue\">599</span>),  329-330.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Bienvenu, B., Ly, K.H., Lambert, M.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2016</span>) <span property=\"dc:title\">Management of giant cell arteritis: recommendations of the French Study Group for Large Vessel Vasculitis (GEFA)</span>. <em>La Revue de Médecine Interne</em> <strong><span rel=\"bibo:volume\">37</span></strong>(<span rel=\"bibo:issue\">3</span>),  154-165.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    BMJ                </span> (<span property=\"dcterms:issued\">2018</span>) <em><span property=\"dc:title\">Giant cell arteritis</span></em>. <span property=\"dc:publisher\">British Medical Journal</span>. <span rel=\"bibo:Website\"><a href=\"https://bestpractice.bmj.com/topics/en-gb/177\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"3e7df89a-b71b-4f96-98ba-ac4500a1228a\">https://bestpractice.bmj.com/topics/en-gb/177</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    BNF                </span> (<span property=\"dcterms:issued\">2020</span>) <em><span property=\"dc:title\">British National Formulary</span></em>. <span property=\"dc:publisher\">BMJ Group and Pharmaceutical Press</span>. <span rel=\"bibo:Website\"><a href=\"https://bnf.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"8cb745bf-b4f8-4ef1-bbcf-abc700e61a0b\">https://bnf.nice.org.uk</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Buttgereit, F.,  Dejaco, C.,  Matteson, E.L. et al.                </span> (<span property=\"dcterms:issued\">2016</span>) <span property=\"dc:title\">Polymyalgia rheumatica and giant cell arteritis: a systematic review</span>. <em>JAMA</em> <strong><span rel=\"bibo:volume\">315</span></strong>(<span rel=\"bibo:issue\">22</span>),  2442-2458. [<span rel=\"bibo:abstract\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/27299619\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"e1fb3e35-9d3c-40db-969f-ac530101a2e7\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Buttgereit F, Matteson EL, Dejaco C and Dasgupta B                </span> (<span property=\"dcterms:issued\">2018</span>) <span property=\"dc:title\">Prevention of glucocorticoid morbidity in giant cell arteritis</span>. <em>Rheumatology (Oxford)</em> <strong><span rel=\"bibo:volume\">57</span></strong>(<span rel=\"bibo:issue\">(suppl_2)</span>).            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    De Smit, E., Palmer, A.J., Hewitt, A.W.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2015</span>) <span property=\"dc:title\">Projected worldwide disease burden from giant cell arteritis by 2050</span>. <em>Journal of Rheumatology</em> <strong><span rel=\"bibo:volume\">42</span></strong>(<span rel=\"bibo:issue\">1</span>),  119-125.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Dejaco, C., Duftner, C., Buttgereit, F.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2017</span>) <span property=\"dc:title\">The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease</span>. <em>Rheumatology (Oxford)</em> <strong><span rel=\"bibo:volume\">56</span></strong>(<span rel=\"bibo:issue\">4</span>),  506-515.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Hazleman, B.L.                </span> (<span property=\"dcterms:issued\">1998</span>) <bookchapter>The vasculitides: polymyalgia rheumatica and giant cell arteritis</bookchapter>.                <text> In: </text>                <span property=\"bibo:editorList\">                    Klippel, J.H. and Dieppe, P.A.                </span><text> (Eds.)</text> <em><span property=\"dc:title\">Rheumatology</span></em>. 2nd edn. London:  <span property=\"dc:publisher\">Mosby International</span>.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Hellmich, B., Agueda, A., Monti, S.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2020</span>) <span property=\"dc:title\">2018 Update of the EULAR recommendations for the management of large vessel vasculitis</span>. <em>Annals of the Rheumatic Diseases</em> <strong><span rel=\"bibo:volume\">79</span></strong>(<span rel=\"bibo:issue\">1</span>),  19-30.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Hoffman, G.                </span> (<span property=\"dcterms:issued\">2016</span>) <span property=\"dc:title\">Giant gell arteritis</span>. <em>Annals of Internal Medicine</em> <strong><span rel=\"bibo:volume\">165</span></strong>(<span rel=\"bibo:issue\">9</span>).            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Hunder, G.G., Bloch, D.A., Michel, B.A.,                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">1990</span>) <span property=\"dc:title\">The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis</span>. <em>Arthritis &amp; Rheumatism</em> <strong><span rel=\"bibo:volume\">33</span></strong>(<span rel=\"bibo:issue\">8</span>),  1122-1128. [<span rel=\"bibo:abstract\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/2202311\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"ed7295e6-150f-4f7e-898f-ab7c00b0209e\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Imran, T.F. and Helfgott, S.                </span> (<span property=\"dcterms:issued\">2015</span>) <span property=\"dc:title\">Respiratory and otolaryngologic manifestations of giant cell arteritis</span>. <em>Clinical and Experimental Rheumatology</em> <strong><span rel=\"bibo:volume\">33</span></strong>(<span rel=\"bibo:issue\">(2 Suppl 89)</span>),  S164-S170.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Kermani TA and Warrington KJ                </span> (<span property=\"dcterms:issued\">2018</span>) <span property=\"dc:title\">Prognosis and monitoring of giant cell arteritis and associated complications</span>. <em>Expert Rev Clin Immunol</em> <strong><span rel=\"bibo:volume\">14</span></strong>(<span rel=\"bibo:issue\">5</span>),  379-388.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Koster, M.J., Matteson, E.L. and Warrington, K.J.                </span> (<span property=\"dcterms:issued\">2018</span>) <span property=\"dc:title\">Large-vessel giant cell arteritis: diagnosis, monitoring and management</span>. <em>Rheumatology (Oxford)</em> <strong><span rel=\"bibo:volume\">57</span></strong>(<span rel=\"bibo:issue\">(suppl_2)</span>).            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Lazarewicz, K. and Watson, P.                </span> (<span property=\"dcterms:issued\">2019</span>) <span property=\"dc:title\">Giant cell arteritis</span>. <em>BMJ</em> <strong><span rel=\"bibo:volume\">365</span></strong>(<span rel=\"bibo:issue\">l1964</span>).            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Ly, K.H., Regent, A., Tamby, M.C.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2010</span>) <span property=\"dc:title\">Pathogenesis of giant cell arteritis: more than just an inflammatory condition?</span> <em>Autoimmunity Reviews</em> <strong><span rel=\"bibo:volume\">9</span></strong>(<span rel=\"bibo:issue\">10</span>),  634-645. [<span rel=\"bibo:abstract\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/20457278\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"4e573d7a-4db3-488b-9ac8-ab7600c7e96c\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Lyons, H.S., Quick, V., Sinclair, A.J.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2020</span>) <span property=\"dc:title\">A new era for giant cell arteritis</span>. <em>Eye (London)</em> <strong><span rel=\"bibo:volume\">34</span></strong>(<span rel=\"bibo:issue\">6</span>),  1013-1026.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Mackie SL, Dasgupta B, Hordon L                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2011</span>) <span property=\"dc:title\">Ischaemic manifestations in giant cell arteritis are associated with area level socio-economic deprivation, but not cardiovascular risk factors</span>. <em>Rheumatology (Oxford)</em> <strong><span rel=\"bibo:volume\">50</span></strong>(<span rel=\"bibo:issue\">11</span>),  2014-2022.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Mackie, S.L., Dejaco, C., Appenzeller, S.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2020a</span>) <span property=\"dc:title\">British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis</span>. <em>Rheumatology</em> <strong><span rel=\"bibo:volume\">59</span></strong>(<span rel=\"bibo:issue\">3</span>). [<span rel=\"bibo:abstract\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/31970405\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"a06a7db1-be98-467e-976c-ab7500cd8fcf\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Mackie, S., Dejaco, C., Appenzeller, S.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2020b</span>) <span property=\"dc:title\">British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis</span>. <em>Rheumatology (Oxford)</em> <strong><span rel=\"bibo:volume\">59</span></strong>(<span rel=\"bibo:issue\">3</span>).            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Mollan, S.P., Paemeleire, K., Versijpt, J.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2020</span>) <span property=\"dc:title\">European Headache Federation recommendations for neurologists managing giant cell arteritis</span>. <em>Journal of Headache and Pain</em> <strong><span rel=\"bibo:volume\">21</span></strong>(<span rel=\"bibo:issue\">1</span>),  28.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    National Institute for Health and Care Excellence (NICE)                </span> (<span property=\"dcterms:issued\">2017</span>) <em><span property=\"dc:title\">Osteoporosis: assessing the risk of fragility fracture</span></em>. <span rel=\"bibo:Website\"><a href=\"https://www.nice.org.uk/Guidance/CG146\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"82ef9438-f2df-4785-807b-ac4500a8f82e\">https://www.nice.org.uk/Guidance/CG146</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2019</span>) <em><span property=\"dc:title\">Suspected neurological conditions: recognition and referral</span></em>. <span property=\"dc:publisher\">National Institute of Health and Care Excellence</span>. <span rel=\"bibo:Website\"><a href=\"http://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"02f3ce37-8458-4727-b6e5-ac530103e39a\">http://www.nice.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"http://www.nice.org.uk/guidance/ng127/resources/suspected-neurological-conditions-recognition-and-referral-pdf-66141663923653\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"bdee4e4a-7053-4d0c-b587-ac530103e3c8\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    National Osteoporosis Guideline Group (NOGG)                </span> (<span property=\"dcterms:issued\">2017</span>) <em><span property=\"dc:title\">National Osteoporosis Guideline Group Clinical guideline for the prevention and treatment of osteoporosis</span></em>. <span rel=\"bibo:Website\"><a href=\"https://www.sheffield.ac.uk/NOGG/NOGG%20Guideline%202017%20July%202019%20Final%20Update%20290719.pdf\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"40bf86c4-8c7a-4427-9b5d-ac4500a88ec4\">https://www.sheffield.ac.uk/NOGG/NOGG%20Guideline%202017%20July%202019%20Final%20Update%20290719.pdf</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Nuenninghoff, D.M., Hunder, G.G., Christianson, T.J.,                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2003</span>) <span property=\"dc:title\">Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years</span>. <em>Arthritis & Rheumatism</em> <strong><span rel=\"bibo:volume\">48</span></strong>(<span rel=\"bibo:issue\">12</span>),  3522-3531. [<span rel=\"bibo:abstract\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/14674004\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"9514f7cf-451d-4f0c-9da7-ab7c00a7d1cc\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Petri, H., Nevitt, A., Sarsour, K.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2015</span>) <span property=\"dc:title\">Incidence of giant cell arteritis and characteristics of patients: data-driven analysis of comorbidities</span>. <em>Arthritis Care & Research</em> <strong><span rel=\"bibo:volume\">67</span></strong>(<span rel=\"bibo:issue\">3</span>),  390-395.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Prior, J.A., Ranjbar, H., Belcher, J.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2017</span>) <span property=\"dc:title\">Diagnostic delay for giant cell arteritis - a systematic review and meta-analysis</span>. <em>BMC Medicine</em> <strong><span rel=\"bibo:volume\">15</span></strong>(<span rel=\"bibo:issue\">1</span>),  120.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Riambau, V., Böckler, D., Brunkwall, J.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2017</span>) <span property=\"dc:title\">Management of descending thoracic aorta diseases: clinical practice guidelines of the European Society for Vascular Surgery (ESVS)</span>. <em>European Journal of Vascular and Endovascular Surgery</em> <strong><span rel=\"bibo:volume\">53</span></strong>(<span rel=\"bibo:issue\">1</span>),  4-52.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Salvarani, C., Cimino, L., Macchioni, P.,                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2005</span>) <span property=\"dc:title\">Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis</span>. <em>Arthritis & Rheumatism</em> <strong><span rel=\"bibo:volume\">53</span></strong>(<span rel=\"bibo:issue\">2</span>),  293-297. [<span rel=\"bibo:abstract\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15818722\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"a5e9bcbf-055e-4830-b7b3-ab7c00a79885\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Salvarani, C., Cantini, F. and Hunder, G.G.                </span> (<span property=\"dcterms:issued\">2008</span>) <span property=\"dc:title\">Polymyalgia rheumatica and giant-cell arteritis</span>. <em>Lancet</em> <strong><span rel=\"bibo:volume\">372</span></strong>(<span rel=\"bibo:issue\">9634</span>),  234-245. [<span rel=\"bibo:abstract\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18640460\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"432b9c19-d337-41d4-9a8d-ab7c00a3d1f3\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Salvarani, C., Cantini, F., Boiardi, L. and Hunder, G.G.                </span> (<span property=\"dcterms:issued\">2002</span>) <span property=\"dc:title\">Polymyalgia rheumatica and giant-cell arteritis</span>. <em>New England Journal of Medicine</em> <strong><span rel=\"bibo:volume\">347</span></strong>(<span rel=\"bibo:issue\">4</span>),  261-271.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Turesson, C., Börjesson, O., Larsson, K.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2019</span>) <span property=\"dc:title\">Swedish Society of Rheumatology 2018 guidelines for investigation, treatment, and follow-up of giant cell arteritis</span>. <em>Scandinavian Journal of Rheumatology</em> <strong><span rel=\"bibo:volume\">48</span></strong>(<span rel=\"bibo:issue\">4</span>),  259-265.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Ungprasert, P., Wijarnpreecha, K., Koster, M.K.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2016a</span>) <span property=\"dc:title\">Cerebrovascular accident in patients with giant cell arteritis: a systematic review and meta-analysis of cohort studies</span>. <em>Seminars in Arthritis and Rheumatism</em> <strong><span rel=\"bibo:volume\">46</span></strong>(<span rel=\"bibo:issue\">3</span>),  361-366.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Ungprasert, P., Thongprayoon, C., Kittanamongkolchai, W.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2016b</span>) <span property=\"dc:title\">Peripheral arterial disease in patients with giant cell arteritis: a meta-analysis</span>. <em>International Journal of Rheumatic Disease</em> <strong><span rel=\"bibo:volume\">19</span></strong>(<span rel=\"bibo:issue\">8</span>),  819-825.            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Vodopivec, I. and Rizzo, J.F.                </span> (<span property=\"dcterms:issued\">2018</span>) <span property=\"dc:title\">Ophthalmic manifestations of giant cell arteritis</span>. <em>Rheumatology (Oxford)</em> <strong><span rel=\"bibo:volume\">57</span></strong>(<span rel=\"bibo:issue\">(suppl_2)</span>).            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Weyand, C.M. and Goronzy, J.J.                </span> (<span property=\"dcterms:issued\">2014</span>) <span property=\"dc:title\">Giant-cell arteritis and polymyalgia rheumatica</span>. <em>New England Journal of Medicine</em> <strong><span rel=\"bibo:volume\">371</span></strong>(<span rel=\"bibo:issue\">1</span>),  50-57. [<span rel=\"bibo:abstract\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277693\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"37cd275f-429d-43f9-9b15-ac5301055881\">Abstract</a></span>]            </span></li></ul><!-- end field 180c409e-3212-4e9c-8510-fa08f5a28422 --><!-- end item 1d40576f-244e-4ae2-add6-4dcb29143f6a -->","topic":{"id":"7eefe727-da7a-5ac5-a30a-dadcb4a4de90","topicId":"922f2e2a-90b2-4d8e-8df9-97f686e2dd9c","topicName":"Giant cell arteritis","slug":"giant-cell-arteritis","lastRevised":"Last revised in September 2020","chapters":[{"id":"28844a63-ce71-58a4-ac10-fb8f990a2ace","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"9ffc44fb-e6ab-5564-afaf-41f6ec23ae59","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"d9822672-70ac-5f30-a37c-163c926d69f9","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"8b641dad-e801-5f07-a15f-837c9e204ae5","slug":"changes","fullItemName":"Changes"},{"id":"b6663d8f-4d43-5493-b6ea-21be0eeae0f0","slug":"update","fullItemName":"Update"}]},{"id":"fbf9fbe8-db19-571e-9da9-58c8a33c3a25","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"4a198ad6-17e2-5c80-a074-90f34f9ef1b7","slug":"goals","fullItemName":"Goals"},{"id":"a77ffdda-deba-58f0-9fec-65219eeb836f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"d0979f67-3177-527b-add9-89f384b45f07","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"c79d9855-b433-5fba-b27d-0999158ea93d","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"941fce5c-cd66-5a8b-94ed-bcdf176a7c54","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"e4b575e0-3a70-5c29-afb2-b56f7ba46307","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a1c8cdf0-c725-5fb8-889a-3531e77f7aeb","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"ea4258e9-d463-5d81-ac84-d12cda80042f","slug":"definition","fullItemName":"Definition"},{"id":"cfe98d94-f2b6-58e5-828a-449fb49d3b2e","slug":"prevalence","fullItemName":"Prevalence"},{"id":"bd2e22a0-2e56-5c05-9b4e-9953cc1765f9","slug":"complications","fullItemName":"Complications"},{"id":"0c5a3725-06fd-5f2f-8aae-4f12da09ec7d","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"4ce95be1-65d5-5341-a648-8f3418d06670","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"c5043d32-5bcd-5396-a271-5864a6d96e74","slug":"suspecting-giant-cell-arteritis","fullItemName":"Suspecting giant cell arteritis"},{"id":"e8c3752d-f9fb-5624-a000-60653edb83ac","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"95e6b3e6-ba05-5b56-8edc-9571fe816995","fullItemName":"Management","slug":"management","subChapters":[{"id":"ecd920ae-cdc1-5314-ba21-3936f06fc825","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"c0f0c8dc-11b9-52b8-ba73-a9c6e75e1731","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"4e1c5dd9-0908-56f2-91a3-604ea1f9e73d","slug":"oral-prednisolone","fullItemName":"Oral prednisolone"}]},{"id":"5a8fb527-3c07-5253-86eb-d10fc0d5b656","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"ff1b1a4d-96ab-5f26-82ea-b4b059ac602f","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"627bf4b4-8b65-59ac-8e48-1f7ac20afa3c","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"403ae553-2865-56af-9e95-a012c674b4de","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"17c8d522-4e76-5f45-aa32-83ed694272f1","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"bb85fa5d-a667-5361-b411-a3837f26bdc3","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"1f292226-0f24-56c9-983b-c8fa1738c13f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"e1a018ae-4d22-516e-8a99-d688c0d3dda6","fullItemName":"References","slug":"references","subChapters":[]}]},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}